EP3176181
Einstofna mótefni gegn CTLA4 eða bindihluti þess, lyfjafræðileg samsetning og notkun
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.7.2015EP published:
23.12.2020EP application number:
15827441.5
EP translation filed:
2.2.2021Grant published:
15.2.2021EPO information:
European Patent Register
Max expiry date:
30.7.2035Expiry date:
30.7.2026Next due date:
31.7.2026
Title:
ANTI-CTLA4 MONOCLONAL ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF, MEDICINAL COMPOSITION AND USE
Timeline
Today
31.7.2015EP application
23.12.2020EP Publication
2.2.2021Translation submitted
15.2.2021Registration published
30.7.2026Expires
Owner
Name:
Akeso Biopharma Inc.Address:
6 Shennong Boulevard Torch Developmental Zone, Zhongshan, Guangdong 528437, CN
Inventor
Name:
LI, BaiyongAddress:
Zhongshan Guangdong 528437, CN
Name:
XIA, YuAddress:
Zhongshan Guangdong 528437, CN
Name:
WANG, ZhongminAddress:
Zhongshan Guangdong 528437, CN
Name:
ZHANG, PengAddress:
Zhongshan Guangdong 528437, CN
Name:
PANG, XinghuaAddress:
Zhongshan Guangdong 528437, CN
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201410377352Date:
1.8.2014Country:
CN
Classification
Categories:
C07K 16/28, C12N 15/13, A61K 39/395, A61P 35/00, A61P 37/04, G01N 33/577, C12N 1/21, C12N 5/10, C12N 15/63, C07K 19/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 24.6.2021
Expires: 30.7.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.6.2022
Expires: 30.7.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 11.7.2023
Expires: 30.7.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 3.7.2024
Expires: 30.7.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.7.2025
Expires: 30.7.2026
Payer: Árnason Faktor ehf.